News Archive 2019
May 29, 2019
T3 Pharmaceuticals awarded highest endowed startup prize
T3 Pharmaceuticals AG wins the W.A. de Vigier Foundation’s highest endowed award for startup companies in Switzerland of CHF 100,000. The spin-off…
May 21, 2019
Treating muscular disease – Santhera and Biozentrum join forces
Santhera Pharmaceuticals and the Biozentrum, University of Basel, announce their collaboration to advance gene therapy research for the treatment of…
May 14, 2019
Relay station in the brain controls our movements
The relay station of the brain, the Substantia Nigra consists of different types of nerve cells and is responsible for controlling the execution of…
March 28, 2019
Crime Scene Schizophrenia - 30 Genes under suspicion
The research group led by Prof. Alex Schier, Director of the Biozentrum, University of Basel, has identified 30 genes associated with schizophrenia.…
March 28, 2019
ERC Advanced Grant for Alex Schier
The European Research Council has awarded the cell and developmental biologist Prof. Alex Schier at the Biozentrum, University of Basel, a generously…
March 25, 2019
Silvia Arber receives the International Prize of the Fyssen Foundation
Prof. Silvia Arber, neurobiologist at the Biozentrum, University of Basel, and the Friedrich Miescher Institute for Biomedical Research (FMI) and new…
March 12, 2019
Urs A. Meyer receives the 2019 Lifetime Achievement Award
Professor Urs A. Meyer, emeritus Professor at the Biozentrum of the University of Basel, has been awarded the "Lifetime Achievement Award 2019" by the…
January 14, 2019
Engineered T cells promote long-term organ transplant acceptance
Organ transplant rejection is a major problem in transplantation medicine. Suppressing the immune system to prevent organ rejection, however, opens…
January 07, 2019
A springboard into research for Bachelor students
With the "Biozentrum Research Summer" program, Bachelor students in the sciences again have the opportunity to immerse themselves in a cutting-edge…